Tumour necrosis factor-α in conjunctivae affected by ocular cicatricial pemphigoid

Acta Ophthalmologica Scandinavica

Volumn 85, Issue 7, 2007, Pages 753-755

  Coma, Miguel Cordero ^a,b   Yilmaz, Taygan ^a   Foster, C Stephen ^a,c,d  

^a MASSACHUSETTS EYE RESEARCH AND SURGERY INSTITUTION   (United States)

^b HOSPITAL DE LEÓN   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Massachusetts Eye Research and Surgery Institute   (United States)

Author keywords

Atopic keratoconjunctivitis; Conjunctiva; Factor alpha; Ocular cicatricial pemphigoid; Tumor necrosis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATOPIC KERATOCONJUNCTIVITIS; CELLULAR DISTRIBUTION; CONJUNCTIVA DISEASE; CONTROLLED STUDY; EPITHELIUM CELL; EYE BIOPSY; EYE DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; OCULAR CICATRICIAL PEMPHIGOID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

BIOPSY; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; HUMANS; IMMUNOENZYME TECHNIQUES; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 35448994836     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2007.00941.x     Document Type: Article

References (17)

1. Ahmed AR, Kurgis BS & Rogers RS (1991): Cicatricial pemphigoid. J Am Acad Dermatol 24: 987-1001.
2. Ameglio F, D'Auria L, Bonifati C, Ferraro C, Mastroianni A & Giacalone B (1998): Cytokine pattern in blister fluid and serum of patents with bullous pemphigoid: Relationships with disease intensity. Br J Dermatol 138: 611-614.
3. Elder MJ, Dart JK & Lightman S (1997): Conjuctival fibrosis in ocular cicatrical pemphigoid: The role of cytokines. Exp Eye Res 65: 165-176.
4. Foster CS (1986): Cicatricial pemphigoid. Thesis for the American Ophthalmological Society. Trans Am Ophthalmol Soc 84: 527-663.
5. Hoang-Xuan T, Foster CS, Raizman MB & Greenwood B (1989): Mast cells in conjuntiva affected by cicatricial pemphigoid. Ophthalmology 96: 1110-1114.
6. Lee SJ, Li Z, Sherman B & Foster CS (1993): Serum levels of tumor necrosis factor-alpha and interleukin-6 in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 34: 3522-3525.
7. Leonardi A, Borghesan F, DePaoli M, Plebani M & Secchi AG (1998): Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal conjunctivitis. Exp Eye Res 67: 105-112.
8. Mease PJ, Kivitz AJ, Burch FX et al. (2004): Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression. Arthritis Rheum 50: 2264-2272.
9. Nash PT & Florin THJ (2005): Tumor necrosis factor inhibitors. Med J Aust 183: 205-208.
10. van de Putte L, Atkins C, Malaise M et al. (2004): Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthtritis for whom previous disease modifying antirheumatic therapy drug treatment has failed. Ann Rheum Dis 63: 508-516.
11. Razzaque MS, Foster CS & Ahmed AR (2002): Role of enhanced expression of M-CSF in conjunctiva affected by cicatricial pemphigoid. Invest Ophthalmol Vis Sci 43: 2977-2983.
12. Razzaque MS, Foster CS & Ahmed AR (2003): Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 44: 1998-2003.
13. Rhodes LE, Hashim IA, McLaughlin PJ & Friedmann PS (1999): Blister fluid cytokines in cutaneous inflammatory bullous disorders. Acta Derm Venereol 79: 288-290.
14. Sacks EH, Jakobiec FA, Wierczorek R, Donnenfeld E, Perry H & Knowles DM Jr. (1989): Immunophenotypic analysis of the inflammatory infiltrate in ocular cicatricial pemphigoid. Further evidence for a T-cell mediated disease. Ophthalmology 96: 236-243.
15. Sandborn W, Hanauer S, Lukas M et al. (2005): Induction and maintenance of clinical remission and response in subjects with Crohn's disease treated with a 6-month open-label period with fully human anti-TNFα monoclonal antibody adalimumab (Humira). Gastroenterology 128: A111.
16. Satici A, Guzey M, Dogan Z & Kilic A (2003): Relationship between tear TNF-α, TGF-β1, and EGF levels and severity of conjunctival cicatrization in patients with inactive trachoma. Ophthalmic Res 35: 301-305.
17. Wajant H, Pfizenmaier K, Scheurich P (2003): Tumor necrosis factor signaling. Cell Death Differ 10: 45-65.